-
1
المؤلفون: Karen Zwaenepoel, Sylvie Rottey, Tijl Vermassen, Astrid De Meulenaere, Philippe Deron, Fréderic Duprez, Sandrine Aspeslagh, Liesbeth Ferdinande
المساهمون: Medical Oncology
المصدر: Pathology
مصطلحات موضوعية: 0301 basic medicine, Oncology, CD4-Positive T-Lymphocytes, Male, Breast Neoplasms/immunology, Carcinoma, Squamous Cell/diagnosis, CD8-Positive T-Lymphocytes, 0302 clinical medicine, Oropharyngeal Neoplasms/diagnosis, Medicine, CD70, Aged, 80 and over, biology, FOXP3, hemic and immune systems, Middle Aged, Prognosis, Oropharyngeal Neoplasms, medicine.anatomical_structure, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Biomarker (medicine), CD27 Ligand/immunology, Female, Mouth Neoplasms, medicine.medical_specialty, T cell, CD3, chemical and pharmacologic phenomena, Breast Neoplasms, CD8-Positive T-Lymphocytes/immunology, Pathology and Forensic Medicine, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, Internal medicine, Mouth Neoplasms/immunology, Humans, Lymphocytes, Tumor-Infiltrating/immunology, Aged, business.industry, Proportional hazards model, CD4-Positive T-Lymphocytes/pathology, Squamous Cell Carcinoma of Head and Neck, Confidence interval, Head and Neck Neoplasms/diagnosis, 030104 developmental biology, biology.protein, Human medicine, business, CD8, CD27 Ligand
-
2
المؤلفون: Bart Neyns, Kris Thielemans, Sandra Tuyaerts, Judith Vandeloo, Ivan Van Riet, An M. T. Van Nuffel, Aude Bonehill, G Verfaillie, Arlette De Coninck, Jurgen Corthals, Carlo Heirman, Daphné Benteyn, Sofie Wilgenhof
المساهمون: Physiology, Skin function and permeability, Hematology, Surgery, Laboratory of Molecullar and Cellular Therapy, Laboratory of Molecular and Medical Oncology, Faculty of Medicine and Pharmacy, Clinical sciences, Medical Oncology, Dermatology, Pathology, Vrije Universiteit Brussel, Immunology and Microbiology, UZB Other, Laboratory for Medical and Molecular Oncology
المصدر: Vrije Universiteit Brussel
مصطلحات موضوعية: Male, Cancer Research, Skin Neoplasms, medicine.medical_treatment, Histocompatibility Antigens Class II/immunology, Skin Neoplasms/drug therapy, Immunology and Allergy, Medicine, Hypersensitivity, Delayed, CD40 Antigens/immunology, Melanoma, Antigens, Neoplasm/immunology, Cancer Vaccines/administration & dosage, Immunogenicity, Vaccination, Evaluable Disease, Middle Aged, Recombinant Proteins, RNA, Messenger/immunology, Electroporation, CD27 Ligand/immunology, Drug Therapy, Combination, Female, immunotherapy, TriMix, Adult, Combination therapy, Interferon-alpha/administration & dosage, Immunology, Drug Therapy, Combination/methods, Dendritic Cells/cytology, Interferon alpha-2, Cancer Vaccines, Antigen, Antigens, Neoplasm, Humans, RNA, Messenger, CD40 Antigens, Adverse effect, dentric cell, Aged, Neoplasm Staging, Pharmacology, business.industry, Toll-Like Receptor 4/immunology, Histocompatibility Antigens Class II, Interferon-alpha, Immunotherapy, Dendritic Cells, medicine.disease, Survival Analysis, Toll-Like Receptor 4, interferon alpha-2b, Hypersensitivity, Delayed/immunology, business, CD27 Ligand